Fexofenadine Market
1 Study Coverage
1.1 Fexofenadine Product Introduction
1.2 Market by Type
1.2.1 Global Fexofenadine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Purity:98%
1.2.3 Purity:Above 98%
1.3 Market by Application
1.3.1 Global Fexofenadine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hay Fever Treatment
1.3.3 Urticaria Treatment
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Fexofenadine Sales Estimates and Forecasts 2017-2028
2.2 Global Fexofenadine Revenue Estimates and Forecasts 2017-2028
2.3 Global Fexofenadine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Fexofenadine Sales by Region
2.4.1 Global Fexofenadine Sales by Region (2017-2022)
2.4.2 Global Sales Fexofenadine by Region (2023-2028)
2.5 Global Fexofenadine Revenue by Region
2.5.1 Global Fexofenadine Revenue by Region (2017-2022)
2.5.2 Global Fexofenadine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Fexofenadine Sales by Manufacturers
3.1.1 Global Top Fexofenadine Manufacturers by Sales (2017-2022)
3.1.2 Global Fexofenadine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Fexofenadine in 2021
3.2 Global Fexofenadine Revenue by Manufacturers
3.2.1 Global Fexofenadine Revenue by Manufacturers (2017-2022)
3.2.2 Global Fexofenadine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Fexofenadine Revenue in 2021
3.3 Global Fexofenadine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Fexofenadine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Fexofenadine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Fexofenadine Sales by Type
4.1.1 Global Fexofenadine Historical Sales by Type (2017-2022)
4.1.2 Global Fexofenadine Forecasted Sales by Type (2023-2028)
4.1.3 Global Fexofenadine Sales Market Share by Type (2017-2028)
4.2 Global Fexofenadine Revenue by Type
4.2.1 Global Fexofenadine Historical Revenue by Type (2017-2022)
4.2.2 Global Fexofenadine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Fexofenadine Revenue Market Share by Type (2017-2028)
4.3 Global Fexofenadine Price by Type
4.3.1 Global Fexofenadine Price by Type (2017-2022)
4.3.2 Global Fexofenadine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Fexofenadine Sales by Application
5.1.1 Global Fexofenadine Historical Sales by Application (2017-2022)
5.1.2 Global Fexofenadine Forecasted Sales by Application (2023-2028)
5.1.3 Global Fexofenadine Sales Market Share by Application (2017-2028)
5.2 Global Fexofenadine Revenue by Application
5.2.1 Global Fexofenadine Historical Revenue by Application (2017-2022)
5.2.2 Global Fexofenadine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Fexofenadine Revenue Market Share by Application (2017-2028)
5.3 Global Fexofenadine Price by Application
5.3.1 Global Fexofenadine Price by Application (2017-2022)
5.3.2 Global Fexofenadine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Fexofenadine Market Size by Type
6.1.1 North America Fexofenadine Sales by Type (2017-2028)
6.1.2 North America Fexofenadine Revenue by Type (2017-2028)
6.2 North America Fexofenadine Market Size by Application
6.2.1 North America Fexofenadine Sales by Application (2017-2028)
6.2.2 North America Fexofenadine Revenue by Application (2017-2028)
6.3 North America Fexofenadine Market Size by Country
6.3.1 North America Fexofenadine Sales by Country (2017-2028)
6.3.2 North America Fexofenadine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Fexofenadine Market Size by Type
7.1.1 Europe Fexofenadine Sales by Type (2017-2028)
7.1.2 Europe Fexofenadine Revenue by Type (2017-2028)
7.2 Europe Fexofenadine Market Size by Application
7.2.1 Europe Fexofenadine Sales by Application (2017-2028)
7.2.2 Europe Fexofenadine Revenue by Application (2017-2028)
7.3 Europe Fexofenadine Market Size by Country
7.3.1 Europe Fexofenadine Sales by Country (2017-2028)
7.3.2 Europe Fexofenadine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Fexofenadine Market Size by Type
8.1.1 Asia Pacific Fexofenadine Sales by Type (2017-2028)
8.1.2 Asia Pacific Fexofenadine Revenue by Type (2017-2028)
8.2 Asia Pacific Fexofenadine Market Size by Application
8.2.1 Asia Pacific Fexofenadine Sales by Application (2017-2028)
8.2.2 Asia Pacific Fexofenadine Revenue by Application (2017-2028)
8.3 Asia Pacific Fexofenadine Market Size by Region
8.3.1 Asia Pacific Fexofenadine Sales by Region (2017-2028)
8.3.2 Asia Pacific Fexofenadine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Fexofenadine Market Size by Type
9.1.1 Latin America Fexofenadine Sales by Type (2017-2028)
9.1.2 Latin America Fexofenadine Revenue by Type (2017-2028)
9.2 Latin America Fexofenadine Market Size by Application
9.2.1 Latin America Fexofenadine Sales by Application (2017-2028)
9.2.2 Latin America Fexofenadine Revenue by Application (2017-2028)
9.3 Latin America Fexofenadine Market Size by Country
9.3.1 Latin America Fexofenadine Sales by Country (2017-2028)
9.3.2 Latin America Fexofenadine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Fexofenadine Market Size by Type
10.1.1 Middle East and Africa Fexofenadine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Fexofenadine Revenue by Type (2017-2028)
10.2 Middle East and Africa Fexofenadine Market Size by Application
10.2.1 Middle East and Africa Fexofenadine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Fexofenadine Revenue by Application (2017-2028)
10.3 Middle East and Africa Fexofenadine Market Size by Country
10.3.1 Middle East and Africa Fexofenadine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Fexofenadine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Viruj Pharma
11.1.1 Viruj Pharma Corporation Information
11.1.2 Viruj Pharma Overview
11.1.3 Viruj Pharma Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Viruj Pharma Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Viruj Pharma Recent Developments
11.2 Cemex Pharma
11.2.1 Cemex Pharma Corporation Information
11.2.2 Cemex Pharma Overview
11.2.3 Cemex Pharma Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cemex Pharma Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cemex Pharma Recent Developments
11.3 Smaart Pharmaceutticals
11.3.1 Smaart Pharmaceutticals Corporation Information
11.3.2 Smaart Pharmaceutticals Overview
11.3.3 Smaart Pharmaceutticals Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Smaart Pharmaceutticals Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Smaart Pharmaceutticals Recent Developments
11.4 Titan Pharma
11.4.1 Titan Pharma Corporation Information
11.4.2 Titan Pharma Overview
11.4.3 Titan Pharma Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Titan Pharma Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Titan Pharma Recent Developments
11.5 AFCL
11.5.1 AFCL Corporation Information
11.5.2 AFCL Overview
11.5.3 AFCL Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AFCL Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AFCL Recent Developments
11.6 Synkromax
11.6.1 Synkromax Corporation Information
11.6.2 Synkromax Overview
11.6.3 Synkromax Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Synkromax Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Synkromax Recent Developments
11.7 Farmhispania
11.7.1 Farmhispania Corporation Information
11.7.2 Farmhispania Overview
11.7.3 Farmhispania Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Farmhispania Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Farmhispania Recent Developments
11.8 Gen Pharma
11.8.1 Gen Pharma Corporation Information
11.8.2 Gen Pharma Overview
11.8.3 Gen Pharma Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Gen Pharma Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Gen Pharma Recent Developments
11.9 Admiron Life Sciences Private Limited
11.9.1 Admiron Life Sciences Private Limited Corporation Information
11.9.2 Admiron Life Sciences Private Limited Overview
11.9.3 Admiron Life Sciences Private Limited Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Admiron Life Sciences Private Limited Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Admiron Life Sciences Private Limited Recent Developments
11.10 JRC
11.10.1 JRC Corporation Information
11.10.2 JRC Overview
11.10.3 JRC Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 JRC Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 JRC Recent Developments
11.11 Archerchem
11.11.1 Archerchem Corporation Information
11.11.2 Archerchem Overview
11.11.3 Archerchem Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Archerchem Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Archerchem Recent Developments
11.12 Sibram
11.12.1 Sibram Corporation Information
11.12.2 Sibram Overview
11.12.3 Sibram Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Sibram Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Sibram Recent Developments
11.13 Sumitomo Chemical
11.13.1 Sumitomo Chemical Corporation Information
11.13.2 Sumitomo Chemical Overview
11.13.3 Sumitomo Chemical Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Sumitomo Chemical Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sumitomo Chemical Recent Developments
11.14 Panchsheel
11.14.1 Panchsheel Corporation Information
11.14.2 Panchsheel Overview
11.14.3 Panchsheel Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Panchsheel Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Panchsheel Recent Developments
11.15 CAMEO HEALTH CARE
11.15.1 CAMEO HEALTH CARE Corporation Information
11.15.2 CAMEO HEALTH CARE Overview
11.15.3 CAMEO HEALTH CARE Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 CAMEO HEALTH CARE Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 CAMEO HEALTH CARE Recent Developments
11.16 CEPiA-Sanofi
11.16.1 CEPiA-Sanofi Corporation Information
11.16.2 CEPiA-Sanofi Overview
11.16.3 CEPiA-Sanofi Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 CEPiA-Sanofi Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 CEPiA-Sanofi Recent Developments
11.17 Va Sudha Pharma Chem Limited
11.17.1 Va Sudha Pharma Chem Limited Corporation Information
11.17.2 Va Sudha Pharma Chem Limited Overview
11.17.3 Va Sudha Pharma Chem Limited Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Va Sudha Pharma Chem Limited Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Va Sudha Pharma Chem Limited Recent Developments
11.18 VPL Chemicals
11.18.1 VPL Chemicals Corporation Information
11.18.2 VPL Chemicals Overview
11.18.3 VPL Chemicals Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 VPL Chemicals Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 VPL Chemicals Recent Developments
11.19 Zhejiang Excel Pharmaceutical
11.19.1 Zhejiang Excel Pharmaceutical Corporation Information
11.19.2 Zhejiang Excel Pharmaceutical Overview
11.19.3 Zhejiang Excel Pharmaceutical Fexofenadine Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Zhejiang Excel Pharmaceutical Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Zhejiang Excel Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Fexofenadine Industry Chain Analysis
12.2 Fexofenadine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Fexofenadine Production Mode & Process
12.4 Fexofenadine Sales and Marketing
12.4.1 Fexofenadine Sales Channels
12.4.2 Fexofenadine Distributors
12.5 Fexofenadine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Fexofenadine Industry Trends
13.2 Fexofenadine Market Drivers
13.3 Fexofenadine Market Challenges
13.4 Fexofenadine Market Restraints
14 Key Findings in The Global Fexofenadine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Fexofenadine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity:98%
Table 3. Major Manufacturers of Purity:Above 98%
Table 4. Global Fexofenadine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Fexofenadine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Fexofenadine Sales by Region (2017-2022) & (MT)
Table 7. Global Fexofenadine Sales Market Share by Region (2017-2022)
Table 8. Global Fexofenadine Sales by Region (2023-2028) & (MT)
Table 9. Global Fexofenadine Sales Market Share by Region (2023-2028)
Table 10. Global Fexofenadine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Fexofenadine Revenue Market Share by Region (2017-2022)
Table 12. Global Fexofenadine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Fexofenadine Revenue Market Share by Region (2023-2028)
Table 14. Global Fexofenadine Sales by Manufacturers (2017-2022) & (MT)
Table 15. Global Fexofenadine Sales Share by Manufacturers (2017-2022)
Table 16. Global Fexofenadine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Fexofenadine Revenue Share by Manufacturers (2017-2022)
Table 18. Fexofenadine Price by Manufacturers (2017-2022) &(USD/MT)
Table 19. Global Fexofenadine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Fexofenadine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fexofenadine as of 2021)
Table 21. Fexofenadine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Fexofenadine Product Offered
Table 23. Date of Manufacturers Enter into Fexofenadine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Fexofenadine Sales by Type (2017-2022) & (MT)
Table 26. Global Fexofenadine Sales by Type (2023-2028) & (MT)
Table 27. Global Fexofenadine Sales Share by Type (2017-2022)
Table 28. Global Fexofenadine Sales Share by Type (2023-2028)
Table 29. Global Fexofenadine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Fexofenadine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Fexofenadine Revenue Share by Type (2017-2022)
Table 32. Global Fexofenadine Revenue Share by Type (2023-2028)
Table 33. Fexofenadine Price by Type (2017-2022) & (USD/MT)
Table 34. Global Fexofenadine Price Forecast by Type (2023-2028) & (USD/MT)
Table 35. Global Fexofenadine Sales by Application (2017-2022) & (MT)
Table 36. Global Fexofenadine Sales by Application (2023-2028) & (MT)
Table 37. Global Fexofenadine Sales Share by Application (2017-2022)
Table 38. Global Fexofenadine Sales Share by Application (2023-2028)
Table 39. Global Fexofenadine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Fexofenadine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Fexofenadine Revenue Share by Application (2017-2022)
Table 42. Global Fexofenadine Revenue Share by Application (2023-2028)
Table 43. Fexofenadine Price by Application (2017-2022) & (USD/MT)
Table 44. Global Fexofenadine Price Forecast by Application (2023-2028) & (USD/MT)
Table 45. North America Fexofenadine Sales by Type (2017-2022) & (MT)
Table 46. North America Fexofenadine Sales by Type (2023-2028) & (MT)
Table 47. North America Fexofenadine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Fexofenadine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Fexofenadine Sales by Application (2017-2022) & (MT)
Table 50. North America Fexofenadine Sales by Application (2023-2028) & (MT)
Table 51. North America Fexofenadine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Fexofenadine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Fexofenadine Sales by Country (2017-2022) & (MT)
Table 54. North America Fexofenadine Sales by Country (2023-2028) & (MT)
Table 55. North America Fexofenadine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Fexofenadine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Fexofenadine Sales by Type (2017-2022) & (MT)
Table 58. Europe Fexofenadine Sales by Type (2023-2028) & (MT)
Table 59. Europe Fexofenadine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Fexofenadine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Fexofenadine Sales by Application (2017-2022) & (MT)
Table 62. Europe Fexofenadine Sales by Application (2023-2028) & (MT)
Table 63. Europe Fexofenadine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Fexofenadine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Fexofenadine Sales by Country (2017-2022) & (MT)
Table 66. Europe Fexofenadine Sales by Country (2023-2028) & (MT)
Table 67. Europe Fexofenadine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Fexofenadine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Fexofenadine Sales by Type (2017-2022) & (MT)
Table 70. Asia Pacific Fexofenadine Sales by Type (2023-2028) & (MT)
Table 71. Asia Pacific Fexofenadine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Fexofenadine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Fexofenadine Sales by Application (2017-2022) & (MT)
Table 74. Asia Pacific Fexofenadine Sales by Application (2023-2028) & (MT)
Table 75. Asia Pacific Fexofenadine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Fexofenadine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Fexofenadine Sales by Region (2017-2022) & (MT)
Table 78. Asia Pacific Fexofenadine Sales by Region (2023-2028) & (MT)
Table 79. Asia Pacific Fexofenadine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Fexofenadine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Fexofenadine Sales by Type (2017-2022) & (MT)
Table 82. Latin America Fexofenadine Sales by Type (2023-2028) & (MT)
Table 83. Latin America Fexofenadine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Fexofenadine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Fexofenadine Sales by Application (2017-2022) & (MT)
Table 86. Latin America Fexofenadine Sales by Application (2023-2028) & (MT)
Table 87. Latin America Fexofenadine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Fexofenadine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Fexofenadine Sales by Country (2017-2022) & (MT)
Table 90. Latin America Fexofenadine Sales by Country (2023-2028) & (MT)
Table 91. Latin America Fexofenadine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Fexofenadine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Fexofenadine Sales by Type (2017-2022) & (MT)
Table 94. Middle East and Africa Fexofenadine Sales by Type (2023-2028) & (MT)
Table 95. Middle East and Africa Fexofenadine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Fexofenadine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Fexofenadine Sales by Application (2017-2022) & (MT)
Table 98. Middle East and Africa Fexofenadine Sales by Application (2023-2028) & (MT)
Table 99. Middle East and Africa Fexofenadine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Fexofenadine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Fexofenadine Sales by Country (2017-2022) & (MT)
Table 102. Middle East and Africa Fexofenadine Sales by Country (2023-2028) & (MT)
Table 103. Middle East and Africa Fexofenadine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Fexofenadine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Viruj Pharma Corporation Information
Table 106. Viruj Pharma Description and Major Businesses
Table 107. Viruj Pharma Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 108. Viruj Pharma Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Viruj Pharma Recent Developments
Table 110. Cemex Pharma Corporation Information
Table 111. Cemex Pharma Description and Major Businesses
Table 112. Cemex Pharma Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 113. Cemex Pharma Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Cemex Pharma Recent Developments
Table 115. Smaart Pharmaceutticals Corporation Information
Table 116. Smaart Pharmaceutticals Description and Major Businesses
Table 117. Smaart Pharmaceutticals Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 118. Smaart Pharmaceutticals Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Smaart Pharmaceutticals Recent Developments
Table 120. Titan Pharma Corporation Information
Table 121. Titan Pharma Description and Major Businesses
Table 122. Titan Pharma Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 123. Titan Pharma Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Titan Pharma Recent Developments
Table 125. AFCL Corporation Information
Table 126. AFCL Description and Major Businesses
Table 127. AFCL Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 128. AFCL Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. AFCL Recent Developments
Table 130. Synkromax Corporation Information
Table 131. Synkromax Description and Major Businesses
Table 132. Synkromax Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 133. Synkromax Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Synkromax Recent Developments
Table 135. Farmhispania Corporation Information
Table 136. Farmhispania Description and Major Businesses
Table 137. Farmhispania Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 138. Farmhispania Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Farmhispania Recent Developments
Table 140. Gen Pharma Corporation Information
Table 141. Gen Pharma Description and Major Businesses
Table 142. Gen Pharma Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 143. Gen Pharma Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Gen Pharma Recent Developments
Table 145. Admiron Life Sciences Private Limited Corporation Information
Table 146. Admiron Life Sciences Private Limited Description and Major Businesses
Table 147. Admiron Life Sciences Private Limited Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 148. Admiron Life Sciences Private Limited Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Admiron Life Sciences Private Limited Recent Developments
Table 150. JRC Corporation Information
Table 151. JRC Description and Major Businesses
Table 152. JRC Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 153. JRC Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. JRC Recent Developments
Table 155. Archerchem Corporation Information
Table 156. Archerchem Description and Major Businesses
Table 157. Archerchem Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 158. Archerchem Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Archerchem Recent Developments
Table 160. Sibram Corporation Information
Table 161. Sibram Description and Major Businesses
Table 162. Sibram Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 163. Sibram Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Sibram Recent Developments
Table 165. Sumitomo Chemical Corporation Information
Table 166. Sumitomo Chemical Description and Major Businesses
Table 167. Sumitomo Chemical Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 168. Sumitomo Chemical Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Sumitomo Chemical Recent Developments
Table 170. Panchsheel Corporation Information
Table 171. Panchsheel Description and Major Businesses
Table 172. Panchsheel Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 173. Panchsheel Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Panchsheel Recent Developments
Table 175. CAMEO HEALTH CARE Corporation Information
Table 176. CAMEO HEALTH CARE Description and Major Businesses
Table 177. CAMEO HEALTH CARE Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 178. CAMEO HEALTH CARE Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. CAMEO HEALTH CARE Recent Developments
Table 180. CEPiA-Sanofi Corporation Information
Table 181. CEPiA-Sanofi Description and Major Businesses
Table 182. CEPiA-Sanofi Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 183. CEPiA-Sanofi Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. CEPiA-Sanofi Recent Developments
Table 185. Va Sudha Pharma Chem Limited Corporation Information
Table 186. Va Sudha Pharma Chem Limited Description and Major Businesses
Table 187. Va Sudha Pharma Chem Limited Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 188. Va Sudha Pharma Chem Limited Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Va Sudha Pharma Chem Limited Recent Developments
Table 190. VPL Chemicals Corporation Information
Table 191. VPL Chemicals Description and Major Businesses
Table 192. VPL Chemicals Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 193. VPL Chemicals Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. VPL Chemicals Recent Developments
Table 195. Zhejiang Excel Pharmaceutical Corporation Information
Table 196. Zhejiang Excel Pharmaceutical Description and Major Businesses
Table 197. Zhejiang Excel Pharmaceutical Fexofenadine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 198. Zhejiang Excel Pharmaceutical Fexofenadine Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Zhejiang Excel Pharmaceutical Recent Developments
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Fexofenadine Distributors List
Table 203. Fexofenadine Customers List
Table 204. Fexofenadine Market Trends
Table 205. Fexofenadine Market Drivers
Table 206. Fexofenadine Market Challenges
Table 207. Fexofenadine Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Fexofenadine Product Picture
Figure 3. Global Fexofenadine Market Share by Type in 2021 & 2028
Figure 3. Purity:98% Product Picture
Figure 4. Purity:Above 98% Product Picture
Figure 5. Global Fexofenadine Market Share by Application in 2021 & 2028
Figure 6. Hay Fever Treatment
Figure 7. Urticaria Treatment
Figure 8. Fexofenadine Report Years Considered
Figure 9. Global Fexofenadine Sales 2017-2028 (MT)
Figure 10. Global Fexofenadine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Fexofenadine Revenue 2017-2028 (US$ Million)
Figure 12. Global Fexofenadine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Fexofenadine Sales Market Share by Region (2017-2022)
Figure 14. Global Fexofenadine Sales Market Share by Region (2023-2028)
Figure 15. North America Fexofenadine Sales YoY (2017-2028) & (MT)
Figure 16. North America Fexofenadine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Fexofenadine Sales YoY (2017-2028) & (MT)
Figure 18. Europe Fexofenadine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Fexofenadine Sales YoY (2017-2028) & (MT)
Figure 20. Asia-Pacific Fexofenadine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Fexofenadine Sales YoY (2017-2028) & (MT)
Figure 22. Latin America Fexofenadine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Fexofenadine Sales YoY (2017-2028) & (MT)
Figure 24. Middle East & Africa Fexofenadine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Fexofenadine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Fexofenadine in the World: Market Share by Fexofenadine Revenue in 2021
Figure 27. Global Fexofenadine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Fexofenadine Sales Market Share by Type (2017-2028)
Figure 29. Global Fexofenadine Revenue Market Share by Type (2017-2028)
Figure 30. Global Fexofenadine Sales Market Share by Application (2017-2028)
Figure 31. Global Fexofenadine Revenue Market Share by Application (2017-2028)
Figure 32. North America Fexofenadine Sales Market Share by Type (2017-2028)
Figure 33. North America Fexofenadine Revenue Market Share by Type (2017-2028)
Figure 34. North America Fexofenadine Sales Market Share by Application (2017-2028)
Figure 35. North America Fexofenadine Revenue Market Share by Application (2017-2028)
Figure 36. North America Fexofenadine Sales Share by Country (2017-2028)
Figure 37. North America Fexofenadine Revenue Share by Country (2017-2028)
Figure 38. U.S. Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Fexofenadine Sales Market Share by Type (2017-2028)
Figure 41. Europe Fexofenadine Revenue Market Share by Type (2017-2028)
Figure 42. Europe Fexofenadine Sales Market Share by Application (2017-2028)
Figure 43. Europe Fexofenadine Revenue Market Share by Application (2017-2028)
Figure 44. Europe Fexofenadine Sales Share by Country (2017-2028)
Figure 45. Europe Fexofenadine Revenue Share by Country (2017-2028)
Figure 46. Germany Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 47. France Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Fexofenadine Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Fexofenadine Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Fexofenadine Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Fexofenadine Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Fexofenadine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Fexofenadine Revenue Share by Region (2017-2028)
Figure 57. China Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 60. India Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Fexofenadine Sales Market Share by Type (2017-2028)
Figure 67. Latin America Fexofenadine Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Fexofenadine Sales Market Share by Application (2017-2028)
Figure 69. Latin America Fexofenadine Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Fexofenadine Sales Share by Country (2017-2028)
Figure 71. Latin America Fexofenadine Revenue Share by Country (2017-2028)
Figure 72. Mexico Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Fexofenadine Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Fexofenadine Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Fexofenadine Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Fexofenadine Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Fexofenadine Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Fexofenadine Revenue Share by Country (2017-2028)
Figure 81. Turkey Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Fexofenadine Revenue (2017-2028) & (US$ Million)
Figure 84. Fexofenadine Value Chain
Figure 85. Fexofenadine Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed